4th Quarter - Report

INFECTIOUS DISEASES SOCIETY OF AMERICA for INFECTIOUS DISEASES SOCIETY OF AMERICA

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$116,112
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 16, 2009 $116,112 Replaced
4th Quarter - Report Jan 20, 2010 $115,820 Replaced
4th Quarter - Amendment Jan 20, 2010 $115,820 Replaced
4th Quarter - Amendment Jun 22, 2010 $115,820 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Infectious Diseases; drug and vaccine research and development; antimicrobial resistance; hospital-acquired infections; immunizations; pandemic influenza, public health security and biodefense; global infectious diseases; biomedical research, reauthorization of President's Emergency Plan for AIDS Relief (PEPFAR); Lyme disease and other infectious diseases issues.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS Director, Public Policy & Government Relations
JULIE HANTMAN Senior Program Officer for Public Health
PADMA NATARAJAN Program Officer for Science and Research
R MICHAEL OCHS Government Relations Associate
ANDREA WEDDLE Executive Director, HIV Medicine Association

Contacted: Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Reimbursement for outpatient infusion therapy; Physician payment cuts; Medicaid and Medicare Reform, including Medicare Prescription Drug Coverage; Average Sales Price; and Competitive Acquistion Program

LobbyistCovered position, as disclosed
ROBERT J GUIDOS Director, Public Policy & Government Relations
R MICHAEL OCHS Government Relations Associate
JASON SCULL Program Officer for Clinical Affairs
ANDREA WEDDLE Executive Director, HIV Medicine Association

Contacted: U.S. Agency for International Development (USAID); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Funding support for the Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health, Health Resources and Services Administration, Food and Drug Administration and global programs for various infectious diseases related issues.

LobbyistCovered position, as disclosed
ROBERT J GUIDOS Director, Public Policy & Government Relations
JULIE HANTMAN Senior Program Officer for Public Health
PADMA NATARAJAN Program Officer for Science and Research
R MICHAEL OCHS Government Relations Associate
ANDREA WEDDLE Executive Director, HIV Medicine Association

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); SENATE

Medical/Disease Research/Clinical Labs MED

Medical liability; Antimicrobial resistance research; infectious diseases product research and development

LobbyistCovered position, as disclosed
ROBERT J GUIDOS Director, Public Policy & Government Relations
JULIE HANTMAN Senior Program Officer for Public Health
PADMA NATARAJAN Program Officer for Science and Research
R MICHAEL OCHS Government Relations Associate

Contacted: U.S. Agency for International Development (USAID); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Affiliated organisations

OrganisationLocation
HIV MEDICINE ASSOCIATION Arlington, VA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.